Roger Perlmutter’s New Biotech Startup Secures $350 Million in Funding

In a significant development in the biotechnology sector, a startup led by industry veteran Roger Perlmutter has successfully raised $350 million. This funding round marks a substantial endorsement for the new venture, which is poised to make impactful advances in biotechnology.

The announcement was made earlier today and has been covered extensively. The investment underscores the confidence investors have in Perlmutter’s vision and the potential of his latest project.

Date: February 26, 2025 

Newsflash | Powered by GeneOnline AI

Related posts:

PepGen’s New Drug Candidate Shows Promising Results in Treating Rare Muscle Disorder The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation What the PlayStation Network Outage Can Teach the Biotech Industry GLP-1 Weight Loss Drugs Might Cause Blindness

Author

Mark Chiang

Ph.D in Biomedical Informatics Head of AI at GeneOnline